5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
April 2021
in “Journal of The European Academy of Dermatology and Venereology”
TLDR 5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.
Several studies suggest that 5-alpha-reductase inhibitors (5ARIs), commonly used to treat androgenetic alopecia (male pattern baldness), may be associated with a reduced frequency of COVID-19 symptoms in males with androgenetic alopecia. The studies found that males with androgenetic alopecia who were taking 5ARIs had a lower likelihood of experiencing COVID-19 symptoms compared to those who were not taking the medication. However, further research is needed to confirm these findings and to determine the mechanism behind this potential association.
View this study on onlinelibrary.wiley.com →
Cited in this study
research Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
AGA linked to worse COVID-19 outcomes in men.
research Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.
research A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
Male pattern hair loss could hint at androgens affecting COVID-19 severity.
research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.
Related
research Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID ‐19 pandemic?
5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.